| Dr Thomas Paulick, DPM | |
|
3500 Meachem Rd, Racine, WI 53405-4662 | |
| (262) 554-7004 | |
| (262) 554-7833 |
| Full Name | Dr Thomas Paulick |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 9 Years |
| Location | 3500 Meachem Rd, Racine, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669726642 | NPI | - | NPPES |
| 100046185 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 1057 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Medical Center Kenosha | Kenosha, WI | Hospital |
| Ascension All Saints Hospital | Racine, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
Current drug development for neuropsychiatric disorders is in crisis, say experts. More than 90 percent of all drugs that are developed for illnesses like schizophrenia, depression, Alzheimer's disease (AD), or the brain tumor glioblastoma complete successful trials in mice but then come to a grinding halt in human trials, wasting billions of dollars in drug research. This is partly because of obvious behavioral differences between the two species.
The brain is bombarded by information about the physical proportions of our bodies. The most familiar sensations, such as a puff of wind or the brush of our own shirt sleeve, serve to constantly remind the brain of the body's outer bounds, creating a sense of what is known as proprioception.
A study led by Mayo Clinic shows for the first time that a drug appears to have a slowing effect - though limited - on the progression from mild cognitive impairment to Alzheimer's disease. The findings will be published online in the New England Journal of Medicine on April 14.
Almost one-third of Yemen's 23 million people do not have enough food, and social unrest in the country is making it difficult for aid groups to reach those in need, Valerie Amos, U.N. under-secretary-general for humanitarian affairs and emergency relief coordinator, said on Monday, Reuters reports.
A small clinical trial of a novel antidepressant that stimulates neurogenesis - the production of new brain cells - shows that the compound appears to be safe and may be effective against depression.
› Verified 7 days ago
| Provider Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609881077 PECOS PAC ID: 8628980943 Enrollment ID: O20031104000421 |
News Archive
Current drug development for neuropsychiatric disorders is in crisis, say experts. More than 90 percent of all drugs that are developed for illnesses like schizophrenia, depression, Alzheimer's disease (AD), or the brain tumor glioblastoma complete successful trials in mice but then come to a grinding halt in human trials, wasting billions of dollars in drug research. This is partly because of obvious behavioral differences between the two species.
The brain is bombarded by information about the physical proportions of our bodies. The most familiar sensations, such as a puff of wind or the brush of our own shirt sleeve, serve to constantly remind the brain of the body's outer bounds, creating a sense of what is known as proprioception.
A study led by Mayo Clinic shows for the first time that a drug appears to have a slowing effect - though limited - on the progression from mild cognitive impairment to Alzheimer's disease. The findings will be published online in the New England Journal of Medicine on April 14.
Almost one-third of Yemen's 23 million people do not have enough food, and social unrest in the country is making it difficult for aid groups to reach those in need, Valerie Amos, U.N. under-secretary-general for humanitarian affairs and emergency relief coordinator, said on Monday, Reuters reports.
A small clinical trial of a novel antidepressant that stimulates neurogenesis - the production of new brain cells - shows that the compound appears to be safe and may be effective against depression.
› Verified 7 days ago
| Provider Name | Aurora Medical Group, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Current drug development for neuropsychiatric disorders is in crisis, say experts. More than 90 percent of all drugs that are developed for illnesses like schizophrenia, depression, Alzheimer's disease (AD), or the brain tumor glioblastoma complete successful trials in mice but then come to a grinding halt in human trials, wasting billions of dollars in drug research. This is partly because of obvious behavioral differences between the two species.
The brain is bombarded by information about the physical proportions of our bodies. The most familiar sensations, such as a puff of wind or the brush of our own shirt sleeve, serve to constantly remind the brain of the body's outer bounds, creating a sense of what is known as proprioception.
A study led by Mayo Clinic shows for the first time that a drug appears to have a slowing effect - though limited - on the progression from mild cognitive impairment to Alzheimer's disease. The findings will be published online in the New England Journal of Medicine on April 14.
Almost one-third of Yemen's 23 million people do not have enough food, and social unrest in the country is making it difficult for aid groups to reach those in need, Valerie Amos, U.N. under-secretary-general for humanitarian affairs and emergency relief coordinator, said on Monday, Reuters reports.
A small clinical trial of a novel antidepressant that stimulates neurogenesis - the production of new brain cells - shows that the compound appears to be safe and may be effective against depression.
› Verified 7 days ago
| Provider Name | Foot & Ankle Specialists Of Racine, S.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457337024 PECOS PAC ID: 1456426675 Enrollment ID: O20080821000519 |
News Archive
Current drug development for neuropsychiatric disorders is in crisis, say experts. More than 90 percent of all drugs that are developed for illnesses like schizophrenia, depression, Alzheimer's disease (AD), or the brain tumor glioblastoma complete successful trials in mice but then come to a grinding halt in human trials, wasting billions of dollars in drug research. This is partly because of obvious behavioral differences between the two species.
The brain is bombarded by information about the physical proportions of our bodies. The most familiar sensations, such as a puff of wind or the brush of our own shirt sleeve, serve to constantly remind the brain of the body's outer bounds, creating a sense of what is known as proprioception.
A study led by Mayo Clinic shows for the first time that a drug appears to have a slowing effect - though limited - on the progression from mild cognitive impairment to Alzheimer's disease. The findings will be published online in the New England Journal of Medicine on April 14.
Almost one-third of Yemen's 23 million people do not have enough food, and social unrest in the country is making it difficult for aid groups to reach those in need, Valerie Amos, U.N. under-secretary-general for humanitarian affairs and emergency relief coordinator, said on Monday, Reuters reports.
A small clinical trial of a novel antidepressant that stimulates neurogenesis - the production of new brain cells - shows that the compound appears to be safe and may be effective against depression.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Paulick, DPM 3500 Meachem Rd, Mount Pleasant, WI 53405-4681 Ph: (262) 554-7004 | Dr Thomas Paulick, DPM 3500 Meachem Rd, Racine, WI 53405-4662 Ph: (262) 554-7004 |
News Archive
Current drug development for neuropsychiatric disorders is in crisis, say experts. More than 90 percent of all drugs that are developed for illnesses like schizophrenia, depression, Alzheimer's disease (AD), or the brain tumor glioblastoma complete successful trials in mice but then come to a grinding halt in human trials, wasting billions of dollars in drug research. This is partly because of obvious behavioral differences between the two species.
The brain is bombarded by information about the physical proportions of our bodies. The most familiar sensations, such as a puff of wind or the brush of our own shirt sleeve, serve to constantly remind the brain of the body's outer bounds, creating a sense of what is known as proprioception.
A study led by Mayo Clinic shows for the first time that a drug appears to have a slowing effect - though limited - on the progression from mild cognitive impairment to Alzheimer's disease. The findings will be published online in the New England Journal of Medicine on April 14.
Almost one-third of Yemen's 23 million people do not have enough food, and social unrest in the country is making it difficult for aid groups to reach those in need, Valerie Amos, U.N. under-secretary-general for humanitarian affairs and emergency relief coordinator, said on Monday, Reuters reports.
A small clinical trial of a novel antidepressant that stimulates neurogenesis - the production of new brain cells - shows that the compound appears to be safe and may be effective against depression.
› Verified 7 days ago
Alliance Foot And Ankle Clinics, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1344 Lathrop Ave, Racine, WI 53405 Phone: 262-731-0077 Fax: 414-282-9948 | |
Nathan D Sockrider, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3500 Meachem Rd, Racine, WI 53405 Phone: 262-554-7004 Fax: 262-554-7833 | |
Foot & Ankle Specialists Of Racine, S.c. Podiatrist Medicare: Medicare Enrolled Practice Location: 3500 Meachem Rd, Racine, WI 53405 Phone: 262-554-7004 Fax: 262-554-7004 | |
Family Foot Clinics Of Wisconsin Sc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 5802 Washington Ave, Suite 103, Racine, WI 53406 Phone: 262-637-8806 Fax: 262-637-2868 | |
Podomedik Clinics Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 425 Shoreland Dr, Racine, WI 53402 Phone: 856-520-4513 | |
Podomedik Clinics Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 425 Shoreland Dr, Racine, WI 53402 Phone: 847-249-3888 | |
Richard A Hill, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3500 Meachem Rd, Racine, WI 53405 Phone: 262-554-7004 Fax: 262-554-7833 |